Unique ID issued by UMIN | UMIN000043580 |
---|---|
Receipt number | R000049767 |
Scientific Title | A prospective observational study on the assessment of nutritional status of nursing home users by using a nutritional assessment web form (MNA Plus) |
Date of disclosure of the study information | 2021/03/18 |
Last modified on | 2023/03/13 10:07:01 |
A prospective observational study on the assessment of nutritional status of nursing home users by using a nutritional assessment web form (MNA Plus)
Assessment of nutritional status using the Nutrition Assessment Web Form (MNA Plus)
A prospective observational study on the assessment of nutritional status of nursing home users by using a nutritional assessment web form (MNA Plus)
Assessment of nutritional status using the Nutrition Assessment Web Form (MNA Plus)
Japan |
healthy adult
Adult |
Others
NO
Nutritional status will be assessed using Mini Nutritional Assessment (MNA) Plus for elderly people using nursing homes, and changes in weight will be investigated for those who are determined to be undernourished and in need of nutritional supplements.
Others
Others
Weight change at 3, 6, 9, and 12 months after the start of observation
Observational
65 | years-old | <= |
Not applicable |
Male and Female
(1) Age 65 years or older at the time of consent.
(2) Patients who have been determined by MNA Plus to be in need of an energy boost at the time of eligibility determination and who are undernourished or at risk of undernourishment
(3) Those who fully understand the contents of the study and are able to give consent.
(1) Patients who are taking nutritional supplements at least once a week at the time of obtaining consent.
(2) Patients who have significant musculoskeletal disorders such as fracture at the time of consent.
(3) Patients who have difficulty in weighing themselves at nursing home.
(4) Patients with severe dementia
(5) Patients who have undergone a surgical operation 4 weeks prior to the start of observation, or who are scheduled to undergo a surgical operation during the observation period
6) Those who are judged by the principal investigator to be inappropriate for this study.
120
1st name | Yukikazu |
Middle name | |
Last name | Kamada |
Nestle Health Science Company, Nestle Japan Ltd
Marketing & Medical Affairs
140-0002
2-2-20 Higashi-Shinagawa, Shinagawa-ku, Tokyo
03-5769-6227
Yukikazu.Kamada@jp.nestle.com
1st name | Hiroki |
Middle name | |
Last name | Takano |
Nestle Health Science Company, Nestle Japan Ltd
Marketing & Medical Affairs
140-0002
2-2-20 Higashi-Shinagawa, Shinagawa-ku, Tokyo
03-5769-6227
Hiroki.Takano@jp.nestle.com
Solasto Corporation
Nestle Japan Ltd
Profit organization
Yamauchi Clinic IRB
1-15-19, Jiyugaoka, Meguro Ku, Tokyo To, Japan
03-5575-5862
c-irb_ug@neues.co.jp
NO
2021 | Year | 03 | Month | 18 | Day |
Unpublished
50
Completed
2021 | Year | 02 | Month | 26 | Day |
2021 | Year | 03 | Month | 18 | Day |
2021 | Year | 04 | Month | 12 | Day |
2022 | Year | 09 | Month | 30 | Day |
2022 | Year | 11 | Month | 30 | Day |
2023 | Year | 01 | Month | 31 | Day |
nothing
2021 | Year | 03 | Month | 10 | Day |
2023 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049767
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |